![logo](/logos/NAUT.webp)
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
2.55 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Nautilus Biotechnology, Inc. |
Symbool | NAUT |
Munteenheid | USD |
Prijs | 2.55 |
Beurswaarde | 319,798,050 |
Dividendpercentage | 0% |
52-weken bereik | 2.19 - 4 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Sujal M. Patel |
Website | https://www.nautilus.bio |
An error occurred while fetching data.
Over Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)